Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
UCB S A (OP: UCBJF)
60.00 USD  UNCHANGED
Last Price  /  Updated: 8:10 PM EDT, May 8, 2013  /  Add to My Watchlist      
View: Quote News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 60.00
Today's Range 60.00 - 60.00
52wk Range 48.35 - 63.84
Shares Outstanding 183,417,352
Dividend Yield N/A
Top News
More News
UPDATE 1-Europe's regulator digs in for drug data fight
April 30, 2013
* EU court stops EMA releasing AbbVie, Intermune drug data Read More
category companyNews
from Reuters: Company News
French and Benelux stocks-Factors to watch on Sept 27
September 27, 2012
PARIS, Sept 27 (Reuters) - Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks. Read More
category companyNews
from Reuters: Company News

More News
Read More
UCB Launches Neupro® in the U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome
July 16, 2012
from Business Wire News Releases
First Assessment of Individual RLS Domains in New Post-Hoc Analyses of Neupro® Studies
April 25, 2012
from Business Wire News Releases
Nodality and UCB Enter into a Multi-Year Strategic Collaboration
February 10, 2012
from Business Wire News Releases
BRIEF-Moody's asgns (P)B2 to Taminco and (P)B1 / (P)Caa1 rtgs to its proposed debt facilities.
January 20, 2012
category companyNews
from Reuters: Company News
Wednesday’s biggest gaining and declining stocks
December 28, 2011
category Earnings , Computer Software , Biotechnology , and 18 more.
from MarketWatch
Long-term Use of Antiepileptic Drug Vimpat® (Lacosamide) C-V Reduced Seizure Frequency and Severity and Improved Health-related Quality of Life Measures
December 05, 2011
from Business Wire News Releases
New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society
November 30, 2011
from Business Wire News Releases
New Data on Patient-Reported Improvements in Quality of Life Measures and Other Clinical Responses in Moderate to Severe Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol) Highlighted a
November 07, 2011
from Business Wire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here